Simulation of symptoms in patients with fibromyalgia

Article Sidebar

PDF (Español (España))
Published: Oct 22, 2017
DOI: https://doi.org/10.17060/ijodaep.2017.n1.v2.967
Keywords:
fibromyalgia chronic pain symptom simulation

Main Article Content

Carlos Barbosa Torres
Universidad de Extremadura
Sixto Cubo Delgado
Universidad de Extremadura
Florencio Vicente Castro
Universidad de Extremadura

Abstract

In this paper we find a study about the variable of simulation of symptoms in fibromyalgia syndrome regarding to other psychological variables such as quality of life, depression, anxiety as well as gradation of pain. The study was performed with 40 patients, all diagnosed with fibromyalgia by the criteria of the American Rheumatology Association. The instruments used were the Structured Inventory of Malingered Symptomatology (SIMS), the Graded Chronic Pain Scale and SF-36 Health Survey (SF-36v2). The results show that there is a relationship between the simulation of symptoms and chronic pain but not with quality of life. The simulation of symptoms in patients with fibromyalgia is a very complex phenomenon that depends on several methods of control among which it is possible to emphasize the use of screening like the SIMS supported with important physical and psychological examinations by experts.

Downloads

Download data is not yet available.

Article Details

How to Cite
Barbosa Torres, C., Cubo Delgado, S., & Vicente Castro, F. (2017). Simulation of symptoms in patients with fibromyalgia. International Journal of Developmental and Educational Psychology. Revista INFAD De Psicología., 2(1), 571–580. https://doi.org/10.17060/ijodaep.2017.n1.v2.967
Issue
Vol. 2 No. 1 (2017): MONOGRAPH NO. 1. PSYCHOLOGY TODAY: CHALLENGES, ACHIEVEMENTS AND PERSPECTIVES OF THE FUTURE. ADOLESCENT PSYCHOLOGY.
Section
Articles
Authors who publish with this journal agree to the following terms:
 
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to copy and redistribute the material in any medium or format under the following terms:

 

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.

 
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
 
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
 
The authors are responsible to obtain the appropriate permissions to reproduce material (text, images or graphics) from other publications and to quote their origin correctly.
 

References

Alonso, J., Priento, L. &Antó, J. M. (1995). La versión española del SF-36 HealthSurvey (Cuestionario de Salud SF-36): Un instrumento para la medida de los resultados clínicos. MedClin, 104, 771-6.

Arostegui Madariaga, I. y Núñez Antón, V. (2008). Aspectos estadísticos del Cuestionario de Calidad de Vida relacionada con salud Short Form-36 (SF-36). Estadística Española, 50(167), 147-192.

Branco, J. C., Bannwarth, B., Failde, I., AbelloCarbonell, J., Blotman, F., Spaeth, M., et al. (2010) Prevalence of fibromyalgia: a survey in five European countries.Semin Arthritis Rheum, 39(6), 448-53.

Breivik, H., Collett, B., Ventafridda, V., Cohen, R., &Gallacher, D. (2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal Of Pain, 10(4), 287-287. http://dx.doi.org/10.1016/j.ejpain.2005.06.009

Capilla Ramirez, GonzalezOrdi y Santamaria (2013). Fibromialgia: ¿exageración o simulación?.Clínica y Salud, 24, 185-195.

Capilla Ramirez, P. y Gonzalez Ordi, H. y Santamaria, P. (2010). Tasas de Prevalencia de simulación de síntomas en población española. Comunicacion presentada en el VIII Congreso Iberoamericano de Psicologia. Oviedo, 20-24 de Junio.

Casals, M. & Samper, D. (2004). Samper Epidemiología, prevalencia y calidad de vida del dolor crónico no oncológico. Estudio ITACA. RevSocEsp Dolor, 11, 260-269

Da Costa, D., Dobkin, P.L., Fitzcharles, M.A., Fortin, P.R., Beaulieu, A., Zummer, M., et al. (2000). Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus. The Journal of Rheumatology, 27, 65-72.

Ferrer Peña, R., Gil Martinez, A., Pardo Montero, J., Jiménez Penick, V. Gallego Izquierdo, T. y La Touche, R. (2015). Adaptación y validación de la Escala de Gradación del dolor crónico al español. ReumatolClin, (3)12, 130-8.

Fitzcharles, M., Shir, Y., Ablin, J., Buskila, D., Amital, H., Henningsen, P., &Häuser, W. (2013). Classification and Clinical Diagnosis of Fibromyalgia Syndrome: Recommendations of Recent Evidence-Based Interdisciplinary Guidelines. Evidence-Based Complementary And Alternative Medicine, 1-9. http://dx.doi.org/10.1155/2013/528952.

Garg, N. &Deodhar, A. (2012). New and modified fibromyalgia diagnostic criteria: Ambiguity, uncertainty, and difficulties complicate diagnosis and management. J MusculoskelMed. 29, 1–5.

González Ordi, H y Santamaría, P. (2009). Adaptación española del Inventario Estructurado de Simulación de Síntomas. Madrid: TEA Ediciones.

González Ordi, H., Santamaría, P. y Capilla, P. (2012). Estrategias de detección de la simulación. Un manual clínico multidisciplinar. Madrid: TEA Ediciones.

Harris, I. A., Murgatroyd, D., Cameron, I., Young, J. M. y Solomon, M. J. (2009). The effect of compensation on health care utilisation in a trauma cohort.The Medical Journal of Australia, 190, 619-22.

Jones, J., Rutledge, D., Jones, K., Matallana, L., & Rooks, D. (2008). Self-Assessed Physical Function Levels Of Women with Fibromyalgia. Women’s Health Issues, 18(5), 406-412. http://dx.doi.org/10.1016/j.whi.2008.04.005

Mease, P., Arnold, L. M., Choy, E. H., Clauw, D. J., Crofford, L. J., Glass, J. M., et al. (2009). Fibromyalgia síndrome module at OMERACT 9: domain construct. J Rheumatol.36 (10), 2318-29.

Merskey, H. &Bogduk, N. (1994).Classification of chronic pain, 2nd. Ed. Seattle, WA:IASP Press.

Miró, J. (2003). Dolor crónico. Procedimientos de evaluación e intervención psicológica. Bilbao, España: Desclée de Brower.

Mittenberg, W., Patton, C., Canyock, E., & Condit, D. (2002).Base Rates of Malingering and Symptom Exeggeration.Journal Of Clinical And Experimental Neuropsychology (Neuropsychology, Development And Cognition: Section A), 24(8), 1094-1102. http://dx.doi.org/10.1076/jcen.24.8.1094.8379

Queiroz, L. P. (2013). Worldwide epidemiology of fibromyalgia.Curr Pain Headache Rep,17(8), 356.

Rivera, J., Rejas, J., Esteve-Vives, J. y Vallejo, M. A. (2009). Costes económicos asociados al diagnóstico de fibromialgia en España. Revista de la Sociedad Española de Dolor, 16, 417-418.

Von Korff, M. (2011) Health services methods. En: Turk DC, Melzack R, editores. Handbook of pain assesment.3rd ed (pp. 455–73) New York: Guilford Press.

Ware J. E. &Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.Med Care, 30(6), 473-83.

Williams, D., &Clauw, D. (2009).Understanding Fibromyalgia: Lessons from the Broader Pain Research Community. The Journal Of Pain, 10(8), 777-791. http://dx.doi.org/10.1016/j.jpain.2009.06.001